Roche to spend $550M building Indianapolis HQ into CGM production hub
The announcement follows a five-year, $50-billion commitment from the Swiss pharma to expand its U.S. footprints in R&D and production.
The announcement follows a five-year, $50-billion commitment from the Swiss pharma to expand its U.S. footprints in R&D and production.
